We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DKNG icon
326
DraftKings
DKNG
$11.9B
$921K 0.07%
+24,615
New +$1.09M
MKSI icon
327
MKS Inc
MKSI
$20.6B
$916K 0.07%
+7,403
New +$789K
TER icon
328
Teradyne
TER
$59.3B
$910K 0.07%
6,614
+4,169
+171% +$455K
ETON icon
329
Eton Pharmaceutcials
ETON
$1.22B
$910K 0.07%
41,873
-1,727
-4% -$28.7K
AKRO
330
DELISTED
Akero Therapeutics
AKRO
$907K 0.07%
19,101
+29
+0.2% +$1.4K
FIX icon
331
Comfort Systems
FIX
$59.6B
$906K 0.07%
1,098
-375
-25% -$254K
USFR icon
332
WisdomTree Floating Rate Treasury Fund
USFR
$18.4B
$905K 0.07%
18,000
– –
CRH icon
333
CRH
CRH
$66.8B
$899K 0.07%
7,495
-125
-2% -$13.2K
PGEN icon
334
Precigen
PGEN
$2.59B
$887K 0.07%
269,511
+138,421
+106% +$391K
MRK icon
335
Merck
MRK
$318B
$884K 0.07%
10,538
+5,001
+90% +$412K
MSOS icon
336
AdvisorShares Pure US Cannabis ETF
MSOS
$880M
$883K 0.07%
+184,371
New +$726K
GS icon
337
Goldman Sachs
GS
$303B
$874K 0.07%
1,098
+602
+121% +$446K
MTAL
338
DELISTED
Metals Acquisition
MTAL
$873K 0.07%
+71,466
New +$866K
TXG icon
339
10x Genomics
TXG
$6.61B
$868K 0.07%
74,238
+21,169
+40% +$276K
JNJ icon
340
Johnson & Johnson
JNJ
$625B
$866K 0.07%
4,671
-519
-10% -$88.9K
MSI icon
341
Motorola Solutions
MSI
$77.4B
$858K 0.07%
+1,877
New +$846K
TNL icon
342
Travel + Leisure Co
TNL
$4.7B
$857K 0.07%
+14,406
New +$865K
ROKU icon
343
Roku
ROKU
$22.7B
$856K 0.07%
+8,545
New +$788K
KVYO icon
344
Klaviyo
KVYO
$4.73B
$848K 0.07%
30,618
+10,004
+49% +$323K
CRBP icon
345
Corbus Pharmaceuticals
CRBP
$190M
$847K 0.07%
66,984
-13,363
-17% -$127K
ZIMV
346
DELISTED
ZimVie
ZIMV
$846K 0.07%
+44,670
New +$756K
GDX icon
347
VanEck Gold Miners ETF
GDX
$27.4B
$846K 0.07%
11,068
-3,992
-27% -$240K
PAYX icon
348
Paychex
PAYX
$42.7B
$844K 0.07%
+6,660
New +$924K
LION icon
349
Lionsgate Studios
LION
$3.86B
$839K 0.07%
121,641
+66,128
+119% +$425K
ECPG icon
350
Encore Capital Group
ECPG
$2.13B
$838K 0.07%
20,068
+36
+0.2% +$1.48K
12 13
14
15 16

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.